Green Elephant Biotech and Bürkert Launch Archimedes® One Dynamic Adherent Bioreactor for Cell Therapy

Green Elephant Biotech has introduced the Archimedes® One, a dynamic adherent bioreactor developed in partnership with Bürkert Fluid Control Systems. This platform simplifies and scales adherent cell culture processes and integrates advanced fluidic control and automation technologies. The system aims to address challenges in biopharmaceutical manufacturing by enabling controlled cultivation and reducing operational complexity. An Early Access Program is being launched for selected cell therapy companies ahead of the planned commercial launch later this year.

Published Mar 21, 2026

Green Elephant Biotech and Bürkert Fluid Control Systems have launched the Archimedes® One, a dynamic adherent bioreactor aimed at simplifying and scaling adherent cell culture processes. Developed from a partnership initiated at analytica 2024, the system integrates advanced fluidic control and automation technologies.

AI-curated by Theia

It offers controlled, perfusion-based cultivation using CellScrew® geometry, enabling precise media and gas flow management while reducing manual intervention. An Early Access Program for selected cell therapy companies is being introduced, allowing them to engage with the technology prior to its commercial launch later this year.